Classification of Myasthenia Gravis Based on Autoantibody Status
Authors:
- Shigeaki SuzukiSSShigeaki Suzuki
- Kimiaki UtsugisawaKUKimiaki Utsugisawa
- Yuriko NaganeYNYuriko Nagane
- Takashi SatohTSTakashi Satoh
- Yasuo TerayamaYTYasuo Terayama
- Norihiro SuzukiNSNorihiro Suzuki
- Masataka KuwanaMKMasataka Kuwana
Open Access
- 1 August 2007
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 64 (8) , 1121-1124
Abstract
Autoantibodies to voltage-gated potassium (Kv) channels are known to be associated with acquired neuromyotonia, Morvan syndrome, and autoimmune nonparaneoplastic limbic encephalitis.1,2 The serum samples of patients with these diseases mainly target members of Kv1 α subunits: Kv1.1, Kv1.2, or Kv1.6.1,2 The expression of these subunits that form Kv channels differs in brain and muscle, and a novel myasthenia gravis (MG)–specific autoantibody to a Kv channel, Kv1.4, was recently identified.3Keywords
This publication has 12 references indexed in Scilit:
- MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravisBrain, 2006
- Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestationsBrain, 2006
- Novel autoantibodies to a voltage-gated potassium channel KV1.4 in a severe form of myasthenia gravisJournal of Neuroimmunology, 2005
- Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitisBrain, 2004
- The occurrence of anti-titin antibodies and thymomasNeurology, 2002
- Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?Neurology, 2001
- The Severity of Myasthenia Gravis Correlates With the Serum Concentration of Titin and Ryanodine Receptor AntibodiesArchives of Neurology, 2000
- Clinical Characteristics and Prognosis of Myasthenia Gravis in Older PeopleJournal of the American Geriatrics Society, 2000
- Myasthenia gravisNeurology, 2000
- Paraneoplastic myasthenia gravis: Detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumorNeurology, 1997